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EDUCATION AND IMAGING
Hepatobiliary and Pancreatic: Giant hepatomegaly from
hepatic hemagiomatosis
A healthy 29-year-old man was presented with a 6-month history
of abdominal discomfort. The patient had no personal or familiar
prior history of relevant diseases or drug consumption.
Physical examination was unremarkable, except for a massive
hepatomegaly. Blood test revealed only a slight elevation of γ-glutamil
transpeptidase (111UI/L; normal range: 15-85UI/L). Abdominal
computed tomography (CT) was the initial imaging assessment and
showed multiple nodules throughout the liver parenchyma.
An abdominal magnetic resonance imaging with contrast, T2
and T1-weighed images, was then performed for further evaluation
(Fig. 1). Abdominal magnetic resonance imaging depicted a giant
hepatomegaly (cranial-caudal diameter: 26.7 cm) (Fig.1a),
countless hepatic conﬂuent nodular lesions with high T2-weighted
signal intensity and centripetal ﬁlling in post-contrast T1-weighted
images (Fig. 1b,c) suggestive of hemangiomas. The hepatic
lesions also caused extrinsic compression of the stomach, hepatic
and portal veins.
Technetium-99 m-labelled Red Blood Cell scan (Tc99m RBC
scan) and the fusion imaging of single-photon emission CT/CT
(Fig. 2) conﬁrmed hepatic hemangiomatosis and excluded
extrahepatic hemangiomas.
Hepatic hemangiomatosis is characterized by diffuse
replacement of hepatic parenchyma with hemangiomatous lesions,
possibly associated with systemic hemangiomas. It is extremely
rare in adults and usually seen in neonates.
Liver failure, consumptive coagulopathy, and high output heart
failure are the most frequent symptoms, contributing to a poor
clinical outcome.
Because of its general rareness and the few cases reported of
long-term adult survival, the underlying etiology, clinical course
and management remain unclear. Previous reports have suggested
the role of estrogen and metoclopramide medications in the
development diffuse hepatic hemangiomatosis. Although, this
association is not yet conﬁrmed.
After multidisciplinary discussion, our patient was referred for
hepatic transplantation.
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Figure 2 Single-photon emission computed tomography/computed
tomography showed abnormal radioactive concentration in whole liver
conﬁrming diffuse hepatic hemangiomatosis (a and b).
Figure 1 Abdominal magnetic resonance imaging showed an
exuberant hepatomegaly (a) and countless hepatic conﬂuent nodular
lesions involving whole liver suggestive of hemangiomas (b and c).
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